Physician profile
Phillip Lee
NPI 1083609317
$9,595.07
in general payments reported to CMS, 2019-2025
12 companies · $184 in 2025
The $184 reported for 2025 was less than what a typical Sleep Medicine (Otolaryngology) provider received nationally (typical 2025 total: $509).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $108 · 2020: $37.05 · 2021: $1,950 · 2022: $50.65 · 2023: $6,934 · 2024: $331 · 2025: $184.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $6,175 · Food and Beverage: $972 · Travel and Lodging: $303.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $6,175.00 |
| Food and Beverage | $971.62 |
| Travel and Lodging | $302.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $9,104.26 | 2021-2025 | Inspire |
| Itamar Medical INC | $156.51 | 2022-2024 | Watchpatone |
| Stryker Corporation | $55.03 | 2019-2020 | |
| Genzyme Corporation | $52.98 | 2019-2024 | |
| Aerin Medical INC. | $46.30 | 2024-2025 | |
| Regeneron Healthcare Solutions, INC. | $45.45 | 2019-2023 | Dupixent |
| Resmed Corp | $41.02 | 2019-2023 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $25.89 | 2023 | Lifevest |
| Intersect Ent, INC. | $22.81 | 2019 | |
| Boston Scientific Corporation | $16.81 | 2024 | |
| Novartis Pharmaceuticals Corporation | $15.11 | 2019 | |
| Glaxosmithkline, LLC. | $12.90 | 2023 | Nucala |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Phillip Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.